Clash of wills to end bioMerieux merger?
This article was originally published in Clinica
Executive Summary
Disagreements between the respective heads bioMerieux and Pierre Fabre over management style appear to have prompted the dismantling of France's largest independent pharmaceutical/healthcare business (see Clinica No 994, p 17).